Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Continued celebrations anticipating the following events coming to fruition:

TPL & PTSC work out differences with increased accountability by TPL

Lawsuits with infringers settled with hefty payments, perhaps with royalties

The waves of licensees signing up to use MMP begins, generating large quarterly profits.

Dividend announced

New CEO announced

PDSG becomes profitable

PTSC announces intention to file for Nasdaq listing

New BoD members elected

Share
New Message
Please login to post a reply